Drugs used for obesity reduction are:
**Core Concept**
The management of obesity involves pharmacological interventions that target various pathways to reduce appetite, increase satiety, and enhance fat metabolism. These drugs can be classified based on their mechanisms of action, including central nervous system (CNS) stimulation, CNS suppression, and peripherally acting agents.
**Why the Correct Answer is Right**
The correct answer involves drugs that work by altering the levels of certain neurotransmitters in the CNS to suppress appetite and increase satiety. For instance, **Orlistat** works by inhibiting pancreatic lipase, an enzyme responsible for fat digestion and absorption. By reducing fat absorption, Orlistat decreases the caloric intake from dietary fats. Other options may involve drugs that directly stimulate or suppress appetite centers in the brain, such as the hypothalamus.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not directly address the management of obesity. While certain medications may have weight loss as a secondary effect, they are not primarily used for obesity reduction.
**Option B:** This option is incorrect as it refers to a medication used for a different indication. Although it may have some impact on weight, it is not a first-line treatment for obesity.
**Option C:** This option is incorrect as it refers to a medication used for a different indication. While it may have some effects on appetite or metabolism, it is not a primary treatment for obesity.
**Clinical Pearl / High-Yield Fact**
When choosing a medication for obesity, it's essential to consider factors such as the patient's overall health, potential side effects, and the presence of any comorbidities. Additionally, lifestyle modifications, including diet and exercise, should always be the first line of treatment for obesity.
**Correct Answer:** C. Orlistat